Cargando…

Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program

Background. Prostate cancer (PCa) is the second most commonly diagnosed cancer, and the sixth most common killer among men worldwide (Aubry et al., 2013). This research was motivated by the fact that PCa screening continues to be a controversial topic in the Kazakh medical community. This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales: Smailova, Dariga S., Fabbro, Elisa, Ibrayev, Serik E., Brusati, Luca, Semenova, Yuliya M., Samarova, Umutzhan S., Rakhimzhanova, Farida S., Zhussupov, Sabit M., Khismetova, Zaituna A., Hosseini, Hengameh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204116/
https://www.ncbi.nlm.nih.gov/pubmed/32411478
http://dx.doi.org/10.1155/2020/6140623
_version_ 1783529996970622976
author Smailova, Dariga S.
Fabbro, Elisa
Ibrayev, Serik E.
Brusati, Luca
Semenova, Yuliya M.
Samarova, Umutzhan S.
Rakhimzhanova, Farida S.
Zhussupov, Sabit M.
Khismetova, Zaituna A.
Hosseini, Hengameh
author_facet Smailova, Dariga S.
Fabbro, Elisa
Ibrayev, Serik E.
Brusati, Luca
Semenova, Yuliya M.
Samarova, Umutzhan S.
Rakhimzhanova, Farida S.
Zhussupov, Sabit M.
Khismetova, Zaituna A.
Hosseini, Hengameh
author_sort Smailova, Dariga S.
collection PubMed
description Background. Prostate cancer (PCa) is the second most commonly diagnosed cancer, and the sixth most common killer among men worldwide (Aubry et al., 2013). This research was motivated by the fact that PCa screening continues to be a controversial topic in the Kazakh medical community. This study aimed at description of how newly diagnosed PCa patients are managed in Pavlodar region of the Kazakhstan Republic and at presentation of a budget impact analysis (BIA) for PCa screening program. Also, we aimed to provide a comparative analysis of pricing system on medical services applied in both private and public healthcare sectors of the Kazakhstan Republic. Methods. New cases of PCa have been retrospectively analyzed for the period from January 2013 to December 2017 based on the information obtained from information system “Policlinic” maintained by the Pavlodar regional branch of the Republican Center for Electronic Health and from Cancer Registry of Pavlodar Regional Oncology Center. All data were analyzed with the help of SPSS 20.0 software. Results. The mean age of PCa patients was 68.34 years (SD = 8.559). The government of Kazakhstan invested 20,437,000 KZT (Kazakhstani tenge) in 2017 equivalently 61,188 USD—to fund a pilot study for examination of 9638 men. From 2013 to 2017, out of 49,334 men residing in Pavlodar region of Kazakhstan 1,248 men were diagnosed with prostate diseases, including 130 PCa cases. The PCa detection rate was equal to two cases per month. Only 22.8% of all PCa cases identified in the region within specified time period were revealed as a result of the government-funded PCa screening program. The average prostate cancer detection rate among the target group of Pavlodar region within the period of 5 years was equal to 0.23%. Conclusion. Based on the fact that the PCa screening program failed to enable adequate detection of new PCa cases, we would not recommend to continue this type of screening unless it is undergone careful revision and replanning.
format Online
Article
Text
id pubmed-7204116
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72041162020-05-14 Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program Smailova, Dariga S. Fabbro, Elisa Ibrayev, Serik E. Brusati, Luca Semenova, Yuliya M. Samarova, Umutzhan S. Rakhimzhanova, Farida S. Zhussupov, Sabit M. Khismetova, Zaituna A. Hosseini, Hengameh Prostate Cancer Research Article Background. Prostate cancer (PCa) is the second most commonly diagnosed cancer, and the sixth most common killer among men worldwide (Aubry et al., 2013). This research was motivated by the fact that PCa screening continues to be a controversial topic in the Kazakh medical community. This study aimed at description of how newly diagnosed PCa patients are managed in Pavlodar region of the Kazakhstan Republic and at presentation of a budget impact analysis (BIA) for PCa screening program. Also, we aimed to provide a comparative analysis of pricing system on medical services applied in both private and public healthcare sectors of the Kazakhstan Republic. Methods. New cases of PCa have been retrospectively analyzed for the period from January 2013 to December 2017 based on the information obtained from information system “Policlinic” maintained by the Pavlodar regional branch of the Republican Center for Electronic Health and from Cancer Registry of Pavlodar Regional Oncology Center. All data were analyzed with the help of SPSS 20.0 software. Results. The mean age of PCa patients was 68.34 years (SD = 8.559). The government of Kazakhstan invested 20,437,000 KZT (Kazakhstani tenge) in 2017 equivalently 61,188 USD—to fund a pilot study for examination of 9638 men. From 2013 to 2017, out of 49,334 men residing in Pavlodar region of Kazakhstan 1,248 men were diagnosed with prostate diseases, including 130 PCa cases. The PCa detection rate was equal to two cases per month. Only 22.8% of all PCa cases identified in the region within specified time period were revealed as a result of the government-funded PCa screening program. The average prostate cancer detection rate among the target group of Pavlodar region within the period of 5 years was equal to 0.23%. Conclusion. Based on the fact that the PCa screening program failed to enable adequate detection of new PCa cases, we would not recommend to continue this type of screening unless it is undergone careful revision and replanning. Hindawi 2020-01-27 /pmc/articles/PMC7204116/ /pubmed/32411478 http://dx.doi.org/10.1155/2020/6140623 Text en Copyright © 2020 Dariga S. Smailova et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Smailova, Dariga S.
Fabbro, Elisa
Ibrayev, Serik E.
Brusati, Luca
Semenova, Yuliya M.
Samarova, Umutzhan S.
Rakhimzhanova, Farida S.
Zhussupov, Sabit M.
Khismetova, Zaituna A.
Hosseini, Hengameh
Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program
title Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program
title_full Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program
title_fullStr Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program
title_full_unstemmed Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program
title_short Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program
title_sort epidemiological and economic evaluation of a pilot prostate cancer screening program
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204116/
https://www.ncbi.nlm.nih.gov/pubmed/32411478
http://dx.doi.org/10.1155/2020/6140623
work_keys_str_mv AT smailovadarigas epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT fabbroelisa epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT ibrayevserike epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT brusatiluca epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT semenovayuliyam epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT samarovaumutzhans epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT rakhimzhanovafaridas epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT zhussupovsabitm epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT khismetovazaitunaa epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram
AT hosseinihengameh epidemiologicalandeconomicevaluationofapilotprostatecancerscreeningprogram